Reviva Pharmaceuticals

(OTC) RVPH

Current Price$0.39

Market Cap$5.55M

Since IPO (2018)-100%

5 Year-100%

1 Year-98%

1 Month-51%

Reviva Pharmaceuticals Financials at a Glance

Market Cap

$5.55M

Revenue (TTM)

$0.00

Net Income (TTM)

-$16.63M

EPS (TTM)

-$4.56

P/E Ratio

-0.09

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$0.39

Volume

77,490

Open

$0.45

Price

$0.39

Volume

77,490

Open

$0.45

Previous Close

$0.43

Daily Range

$0.39 - $0.45

52-Week Range

$0.26 - $20.20

Dividend

$0.00

Beta (Volatility)

0.82 (Low)

Price

$0.39

Volume

77,490

Open

$0.45

Previous Close

$0.43

Daily Range

$0.39 - $0.45

52-Week Range

$0.26 - $20.20

RVPH News

Reviva Narrows Loss 23% in Fiscal Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Reviva Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Laxminarayan Bhat, PhD

Website

www.revivapharma.com

Headquarters

Cupertino, CA 95014, US

RVPH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-256%

Return on Capital

-97%

Return on Assets

-71%

Earnings Yield

-11.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.55M

Shares Outstanding

12.81M

Volume

77.49K

Avg. Volume

821.39K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$20.20M

EBITDA

-$19.83M

Operating Cash Flow

-$24.59M

Capital Expenditure

$0.00

Free Cash Flow

-$24.59M

Cash & ST Invst.

$14.44M

Total Debt

$406.88K

Reviva Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.55M

N/A

Market Cap/Employee

$396.21K

N/A

Employees

N/A

Net Income

-$3.20M

+50.3%

EBITDA

-$3.19M

+50.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$21.96M

+333.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$231.27K

+3.1%

Return on Assets

-70.58%

N/A

Return on Invested Capital

-97.09%

N/A

Free Cash Flow

-$3.80M

+53.6%

Operating Cash Flow

-$3.80M

+53.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCABBioAtla, Inc.

BCABBioAtla, Inc.$3.94-2.72%

CELUCelularity Inc.

CELUCelularity Inc.$0.99+0.01%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$4.05-1.27%

TVRDTvardi Therapeutics, Inc.

TVRDTvardi Therapeutics, Inc.$3.34-4.30%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.19-5.56%

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$1.91+0.26%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.99-0.02%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$42.52+0.11%

REPLReplimune Group

REPLReplimune Group$8.78+0.88%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.28-0.01%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$109.57-0.18%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$7.19+0.27%

SMCISuper Micro Computer

SMCISuper Micro Computer$45.61+0.10%

Questions About RVPH

What is the current price of Reviva Pharmaceuticals?

Reviva Pharmaceuticals is trading at $0.39 per share.

What is the 52-week range for Reviva Pharmaceuticals?

Over the past 52 weeks, Reviva Pharmaceuticals has traded between $0.26 and $20.20.

How much debt does Reviva Pharmaceuticals have?

As of the most recent reporting period, Reviva Pharmaceuticals reported total debt of $231.27K.

How much cash does Reviva Pharmaceuticals have on hand?

Reviva Pharmaceuticals reported $22.19M in cash and cash equivalents in its most recent financial results.

What is Reviva Pharmaceuticals’s dividend yield?

Reviva Pharmaceuticals does not currently have a dividend yield.

Reviva Pharmaceuticals

Reviva Pharmaceuticals Financials at a Glance

RVPH News

Reviva Narrows Loss 23% in Fiscal Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Reviva Pharmaceuticals

RVPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Reviva Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RVPH

What is the current price of Reviva Pharmaceuticals?

What is the 52-week range for Reviva Pharmaceuticals?

How much debt does Reviva Pharmaceuticals have?

How much cash does Reviva Pharmaceuticals have on hand?

What is Reviva Pharmaceuticals’s dividend yield?

Premium Investing Services